Filing Details
- Accession Number:
- 0001708138-21-000080
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-15 16:02:17
- Reporting Period:
- 2021-09-13
- Accepted Time:
- 2021-09-15 16:02:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1437435 | Marc Tessier-Lavigne | 777 Old Saw Mill River Road Tarrytown NY 10591 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-09-13 | 4,250 | $273.67 | 6,328 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-09-13 | 4,250 | $273.67 | 10,578 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-09-13 | 4,250 | $273.67 | 14,828 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-09-13 | 816 | $636.64 | 14,012 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 816 | $637.71 | 13,196 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 2,098 | $638.46 | 11,098 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 1,260 | $639.45 | 9,838 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 981 | $640.61 | 8,857 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 952 | $641.56 | 7,905 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 1,645 | $642.54 | 6,260 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 1,549 | $643.33 | 4,711 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 844 | $644.52 | 3,867 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 61 | $645.21 | 3,806 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 354 | $646.24 | 3,452 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 425 | $647.39 | 3,027 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 381 | $648.25 | 2,646 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 124 | $649.35 | 2,522 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 56 | $650.33 | 2,466 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 249 | $651.54 | 2,217 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 139 | $652.26 | 2,078 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-09-13 | 4,250 | $0.00 | 4,250 | $273.67 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-09-13 | 4,250 | $0.00 | 4,250 | $273.67 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-09-13 | 4,250 | $0.00 | 4,250 | $273.67 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,500 | 2024-01-02 | No | 4 | M | Direct | |
| 4,250 | 2024-01-02 | No | 4 | M | Direct | |
| 0 | 2024-01-02 | No | 4 | M | Direct |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 816 shares of Company stock on September 13, 2021 at prices ranging from $636.08 to $636.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
- Represents volume-weighted average price of sales of 816 shares of Company stock on September 13, 2021 at prices ranging from $637.26 to $637.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
- Represents volume-weighted average price of sales of 2,098 shares of Company stock on September 13, 2021 at prices ranging from $638.00 to $638.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
- Represents volume-weighted average price of sales of 1,260 shares of Company stock on September 13, 2021 at prices ranging from $639.00 to $639.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
- Represents volume-weighted average price of sales of 981 shares of Company stock on September 13, 2021 at prices ranging from $640.18 to $640.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
- Represents volume-weighted average price of sales of 952 shares of Company stock on September 13, 2021 at prices ranging from $641.01 to $641.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
- Represents volume-weighted average price of sales of 1,645 shares of Company stock on September 13, 2021 at prices ranging from $642.00 to $642.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
- Represents volume-weighted average price of sales of 1,549 shares of Company stock on September 13, 2021 at prices ranging from $643.01 to $643.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
- Represents volume-weighted average price of sales of 844 shares of Company stock on September 13, 2021 at prices ranging from $644.03 to $644.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
- Represents volume-weighted average price of sales of 61 shares of Company stock on September 13, 2021 at prices ranging from $645.21 to $645.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
- Represents volume-weighted average price of sales of 354 shares of Company stock on September 13, 2021 at prices ranging from $646.04 to $646.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
- Represents volume-weighted average price of sales of 425 shares of Company stock on September 13, 2021 at prices ranging from $647.06 to $647.67. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
- Represents volume-weighted average price of sales of 381 shares of Company stock on September 13, 2021 at prices ranging from $648.06 to $648.58. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
- Represents volume-weighted average price of sales of 124 shares of Company stock on September 13, 2021 at prices ranging from $649.27 to $649.43. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
- Represents volume-weighted average price of sales of 249 shares of Company stock on September 13, 2021 at prices ranging from $651.10 to $651.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
- The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
